The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Methyl-N-(3-pyridin-2-yl-isoquinolin-1-yl)-benzamide ID: ALA339261
Cas Number: 112575-49-2
PubChem CID: 10359831
Max Phase: Preclinical
Molecular Formula: C22H17N3O
Molecular Weight: 339.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C(=O)Nc2nc(-c3ccccn3)cc3ccccc23)cc1
Standard InChI: InChI=1S/C22H17N3O/c1-15-9-11-16(12-10-15)22(26)25-21-18-7-3-2-6-17(18)14-20(24-21)19-8-4-5-13-23-19/h2-14H,1H3,(H,24,25,26)
Standard InChI Key: XKGYBIWGVCSKAC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.3875 -0.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8708 0.1458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3875 -0.7542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9125 -1.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8708 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9083 0.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3958 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9083 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9125 -1.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3500 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1667 0.7583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4333 -0.7542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4375 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4000 -1.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4000 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4458 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9250 -2.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4250 1.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4250 -0.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6875 1.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3625 1.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9333 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9500 0.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6750 1.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9500 0.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1500 1.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 3 1 0
5 2 1 0
6 1 1 0
7 8 1 0
8 6 1 0
9 4 1 0
10 5 1 0
11 10 2 0
12 4 2 0
13 9 2 0
14 9 1 0
15 14 2 0
16 13 1 0
17 15 1 0
18 8 2 0
19 6 2 0
20 11 1 0
21 10 1 0
22 17 1 0
23 25 2 0
24 26 1 0
25 19 1 0
26 21 2 0
5 7 2 0
18 23 1 0
16 17 2 0
20 24 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.40Molecular Weight (Monoisotopic): 339.1372AlogP: 4.86#Rotatable Bonds: 3Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.96CX LogP: 5.15CX LogD: 5.15Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.58Np Likeness Score: -1.11
References 1. van Muijlwijk-Koezen JE, Timmerman H, Link R, van der Goot H, Ijzerman AP.. (1998) A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds., 41 (21): [PMID:9767637 ] [10.1021/jm980037i ] 2. de Zwart MA, van der Goot H, Timmerman H.. (1988) Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. Amides., 31 (4): [PMID:3351847 ] [10.1021/jm00399a005 ] 3. Tafi A, Bernardini C, Botta M, Corelli F, Andreini M, Martinelli A, Ortore G, Baraldi PG, Fruttarolo F, Borea PA, Tuccinardi T.. (2006) Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models., 49 (14): [PMID:16821770 ] [10.1021/jm051112+ ]